Difference between revisions of "Team:NCTU Formosa"

Line 205: Line 205:
 
         <div class="div3-2">
 
         <div class="div3-2">
 
  <div class="photo3-2"></div>
 
  <div class="photo3-2"></div>
−
      <div class="photocontent2"><h2>What we do</h2>
+
      <div class="photocontent2"><h2>What's new</h2>
−
We want to help doctor to select the
+
  Our organization create a customized scFv detection platform by co-transforming any desired combination of plasmids. ScFv utilizing antigen-antibody-interaction can act as probes. Our ecotector can therefore have the function of a detector.
−
candidates for targeted drug therapies and
+
      </div> </div>
−
determine what kinds of targeted drugs can  
+
−
be used in a cheaper way. If the diagnosis cost
+
−
become inexpensive, there will be more people
+
−
can afford, therefore more people can be
+
−
prescribe and treated, decreasing the mortality rate.</div>
+
−
      </div>
+
 
              
 
              
 
           <div class="div3-3">
 
           <div class="div3-3">
 
    <div class="photo3-3"></div>
 
    <div class="photo3-3"></div>
−
   
+
           
−
        <div class="photocontent3"><h2>What's new</h2>
+
        <div class="photocontent3"><h2>What we care</h2>
 
        APOllO E.Cotector:<br>
 
        APOllO E.Cotector:<br>
−
Our organization create a customized scFv detection platform by co-transforming any desired combination of plasmids. ScFv utilizing antigen-antibody-interaction can act as probes. Our ecotector can therefore have the function of a detector.<br>
+
In 2015, we focus on helping doctors select the appropriate candidates for monoclonal-antibody targeted drug for patient's treatment in a more inexpensive way. If the cost for diagnosis decreases, more people can afford it. Therefore, more people can be prescribed and treated, lowering the mortality rate of cancer.<br>
 
             </div>
 
             </div>
 
      </div>
 
      </div>

Revision as of 17:21, 13 September 2015

1
The only thing we detect is everything.

Who are we

NCTU_Formosa created an organization-APOllO, which stands for Almighty Probe of scFv Organization. APOllO devoted to developing detection technology by utilizing antibodies. In 2015, We cooperated with iGEM with Synthetic Biology to develop a brand new detection platform.

What's new

Our organization create a customized scFv detection platform by co-transforming any desired combination of plasmids. ScFv utilizing antigen-antibody-interaction can act as probes. Our ecotector can therefore have the function of a detector.

What we care

APOllO E.Cotector:
In 2015, we focus on helping doctors select the appropriate candidates for monoclonal-antibody targeted drug for patient's treatment in a more inexpensive way. If the cost for diagnosis decreases, more people can afford it. Therefore, more people can be prescribed and treated, lowering the mortality rate of cancer.